ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGY Allergy Therapeutics Plc

7.40
0.20 (2.78%)
07 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 2.78% 7.40 6.70 7.50 7.24 6.90 7.10 444,115 16:35:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 55.2M -40.22M -0.0084 -8.45 343.18M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 7.20p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 1.88p to 7.25p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £343.18 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -8.45.

Allergy Therapeutics Share Discussion Threads

Showing 4701 to 4722 of 5375 messages
Chat Pages: Latest  191  190  189  188  187  186  185  184  183  182  181  180  Older
DateSubjectAuthorDiscuss
19/6/2023
13:23
What if it doesn't...will you stop posting lol
zen12
19/6/2023
12:15
Will fall to 1p -
tomboyb
19/6/2023
11:45
impo
You act in haste and repent at leisure
DYOR

jimmyloser
19/6/2023
11:34
Is this going to be a hold or fold? I've just trimmed my holding by half for now..hoping for something positive out of this
amishp67
19/6/2023
11:28
A change of spectacles may help!

We are going through severe turbulence, nothing more.

impo.

jimmyloser
19/6/2023
10:36
4billion+ shares to come in at 1p -

At the moment looks like a basket case -

tomboyb
19/6/2023
10:26
It was a lot wider just before I posted.
babbler
19/6/2023
09:50
A few bargain hunters at this low price. Would have expected more activity though.
robertjt
19/6/2023
09:34
lovl in between the tears...........we are looking at insanity on our screens.
jimmyloser
19/6/2023
09:02
1.50 to sell 1.65 to buy not too bad
mally6
19/6/2023
08:56
With that spread you'd need almost a bagger to break even .
babbler
19/6/2023
08:52
At least we have some sort of liquidity back, so yes, a nice start. Remember, the alternative was that the Insiders' FDI applications failed and (thanks to the deal done by our inspired board) the company would have been handed to the Insiders.
Looking for small mercies to be thankful for, maybe, but it seems the legal protections and the threat of a stock exchange investigation has kept everyone honest(ish).
Now is not a time to reduce our vigilance, however. The next big risk to us is any new financing - the £40m cram-down we are currently enduring will not, apparently, suffice.

1kckeith
19/6/2023
08:45
This does look cheap at this price maybe a bagger from here at least
mally6
19/6/2023
07:41
He's not!.But his glass is always, naivily 'half full.
lean5gb
19/6/2023
07:32
He is short so yeah.
babbler
19/6/2023
07:21
60% down, and nice start lol
zen12
19/6/2023
07:15
Nice start to the day!
jpuff
19/6/2023
06:05
Allergy Therapeutics PLC Interim Results and Lifting Suspension in Trading
19/06/2023 7:01am
UK Regulatory (RNS & others)

Allergy Therapeutics (LSE:AGY)
Intraday Stock Chart

Monday 19 June 2023

Click Here for more Allergy Therapeutics Charts.
TIDMAGY

RNS Number : 0740D

Allergy Therapeutics PLC

19 June 2023

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company" or the "Group")

Interim Results for the six months ended 31 December 2022

and Lifting of Suspension in Trading

19 June 2023: Allergy Therapeutics plc (AIM: AGY), the integrated commercial biotechnology company specialising in allergy vaccines, announces its unaudited interim results for the six months ended 31 December 2022 and expected restoration of trading in the Company's ordinary shares on AIM with effect from 7.30am today .

wizzkid211
09/6/2023
07:59
When I read these RNS of this company and this manager I am in conflict with two opposing deep personal feelings.
I don't know whether to laugh at how this company can boast of presenting studies with a scientific value close to zero as posters at the most important scientific congress in the sector: scientific value 0.000001. Or to organize a symposium essentially made up of promises that this company, I remember close to being financially insolvent, promises it NEVER kept.
The other conflicting feeling is irritation. Because this manager and this company consider us ignorant fools.
Tick ,tick,tick.

beccasan
09/6/2023
07:03
Positive news this morning and more evidence to me as to why this is worth fighting for.Tick tick, the end of June.Impo
jimmyloser
07/6/2023
07:33
The clock is certainly ticking and with each passing day it seems to tick a little louder. Where are the RNS's?What a mess we appear to be in, not at all Allergy T. as we know it.However I remain (possibly naively) positive and mildly optimistic on the potential and outlook.Read the reports on both of the trials and it becomes clearer as to why they won't just let this go. They are sitting on potentially several multi million dollar blockbusters.I like everyone else don't like this current situation but expect and hope that they can and will get their ducks in a row and start the long road back to gaining our credibility back.We need to start the news flow soon but of course, we all know that.ImpoJl
jimmyloser
26/5/2023
15:10
I hate to say it, but I told you all this would happen.
coinbase
Chat Pages: Latest  191  190  189  188  187  186  185  184  183  182  181  180  Older

Your Recent History

Delayed Upgrade Clock